ReviewExpert opinion on therapeutic patents2022

Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property.

Piyusha P Pagare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.